北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (4): 597-602. doi: 10.3969/j.issn.1671-167X.2017.04.008

• 论著 • 上一篇    下一篇

肾癌根治性切除加癌栓取出术治疗Mayo Ⅲ级下腔静脉癌栓的手术技术及临床经验

刘茁,马潞林△,田晓军,王国良,侯小飞,张树栋,邓绍晖   

  1. (北京大学第三医院泌尿外科, 北京100191)
  • 出版日期:2017-08-18 发布日期:2017-08-18
  • 通讯作者: 马潞林 E-mail: malulin@medmail.com.cn

Radical nephrectomy and thrombectomy for Mayo clinic stage Ⅲ tumor thrombus: a surgical technique and clinical experience

LIU Zhuo, MA Lu-lin△, TIAN Xiao-jun, WANG Guo-liang, HOU Xiao-fei, ZHANG Shu-dong, DENG Shao-hui   

  1. (Department of Urology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2017-08-18 Published:2017-08-18
  • Contact: MA Lu-lin E-mail: malulin@medmail.com.cn

摘要: 目的:探讨肾癌根治性切除加下腔静脉癌栓取出术治疗Mayo Ⅲ级下腔静脉癌栓(inferior vena cava tumor thrombus,IVCTT)的有效性和安全性,总结手术技术及临床经验。方法:回顾性分析2014年10月至2016年9月北京大学第三医院泌尿外科收治的8例肾癌合并Mayo Ⅲ级(美国Mayo医学中心分级法)IVCTT患者的临床资料。8例患者中男性3例,女性5例,年龄18~77岁,平均(58.0±18.7)岁,体重指数(body mass index,BMI)为15.2~30.8 kg/m2,平均(22.7±4.4) kg/m2。8例患者的肿瘤均位于右侧,肿瘤直径(7.9±2.5) cm。行开放肾癌根治性切除加下腔静脉癌栓取出术者5例,行腹腔镜下肾癌根治性切除加下腔静脉癌栓取出术者3例,其中1例患者行中转开放手术。结果:8例患者手术均顺利完成,无围术期死亡病例。手术时间272~567 min,平均(370.3±101.6) min。下腔静脉阻断时间17~55 min,平均(41.0±12.1) min。术中出血量200~3 000 mL,平均(1 181.3±915.7) mL。术中输注悬浮红细胞者5例,输入量800~2 000 mL,平均(850.0±783.8) mL。术中输注血浆者3例,输入量400~1 000 mL。术后住院时间9~23 d,平均(14.1±4.0) d。8例患者中4例因术中发现癌栓侵犯下腔静脉壁而行下腔静脉壁切除术。8例患者术前血肌酐值60~101 μmol/L,平均(76.4±15.3) μmol/L,术后1周血肌酐值74~127 μmol/L,平均(100.8±21.1) μmol/L。术后组织病理检查诊断为肾透明细胞癌(renal clear cell carcinoma,RCC)6例,肾乳头状腺癌(papillary adenocarcinoma)1例,Fuhrman分级为Ⅲ级6例、Ⅳ级1例,尤文肉瘤(Ewing’s sarcoma)1例。8例患者中,5例发生术后早期并发症,均为ClavienⅡ级并发症,未见严重并发症发生。8例患者均获随访,随访时间2~24个月,平均11.3个月。术前未发现远处转移的7例患者中,出现远处转移1例,为肺转移。结论:肾癌根治性切除加下腔静脉癌栓取出术治疗Mayo Ⅲ级下腔静脉癌栓较为有效、安全。Ⅲ级静脉癌栓延伸范围广,手术技术难度较大,充分的术前准备、丰富的解剖学知识和手术操作经验可提高手术安全性。

关键词:  肾肿瘤, 癌栓, 腔静脉,

Abstract: Objective: To evaluate the effectiveness and safety of radical nephrectomy and inferior vena cava thrombectomy in the treatment of patients with Mayo Ⅲ tumor thrombus, and to introduce our experience and surgical technique. Methods: The clinical data of 8 patients with Mayo Ⅲ tumor thrombus from October 2014 to September 2016 were analyzed retrospectively. Of the 8 patients, 3 were male and 5 were female. The average age was (50.8±18.7) years (18 to 77 years). The average body mass index (BMI) was (22.7±4.4) kg/m2 (15.2 to 30.8 kg/m2). Imaging suggested the right renal tumor in all the 8 cases. The average tumor size was (7.9±2.5) cm. Open radical nephrectomy and inferior vena cava thrombectomy was conducted in 5 cases and laparoscopic surgery in 3 cases, and 1 case was converted to open surgery. Results: All the 8 surgeries were completed successfully with no death case. The average surgery time was (370.3±101.6) min, ranging from 272-567 min. The average vena cava blocked time was (41.0±12.1) min, ranging from 17-55 min. The blood loss volume was (1 181.3±915.7) mL, ranging from 200-3 000 mL. During the operation, 5 cases were infused with suspended red blood cells, the amount of blood transfusion was 800-2 000 mL. 3 cases were infused of plasma with 400-1 000 mL. The average hospital stay was 9-23 d, with an average of (14.1±4.0) d. In the 8 patients, 4 cases underwent inferior vena cava wall resection because of invasion by tumor thrombus. Preoperative serum creatinine was 60-101 μmol/L, with an average of (76.4±15.3) μmol/L. Serum creatinine 1 week after the operation was 74-127 μmol/L, with an average of (100.8±21.1) μmol/L. Pathological diagnosis showed 6 cases of clear cell carcinoma, 1 case of papillary carcinoma type Ⅱ, and 1 case of Ewing’s sarcoma. Among the 8 patients, early postoperative complications occurred in 5 cases. Postoperative complications were graded as level Ⅱ, according to the Clavien classifications. The 8 cases were followed up for 2 to 24 months with an average of 11.3 months. There was 1 patient who suffered from lung metastasis. Conclusion: Our initial clinical results show that radical nephrectomy and inferior vena cava thrombectomy is safe and effective for patients with Mayo Ⅲ tumor thrombus. The wide extension of grade Ⅲ vein tumor thrombus leads to the difficulty of operation technique. Sufficient preoperative preparation, rich operative experience and skills can improve the safety of operation.

Key words: Kidney neoplasms, Tumor thrombus, Vena cava, inferior

中图分类号: 

  • R737.11
[1] 王昕莹, 程雪原, 张孟钧, 李菲, 段晋瑜, 乔静. 浓缩生长因子联合引导性组织再生术治疗下颌磨牙根分叉病变的疗效[J]. 北京大学学报(医学版), 2026, 58(2): 372-379.
[2] 单珅瑶, 杨咏涛, 李文博, 温奥楠, 高梓翔, 商相宜, 王勇, 赵一姣. 基于下颌运动轨迹的𬌗架关键参数计算方法[J]. 北京大学学报(医学版), 2026, 58(1): 115-125.
[3] 杨雨婷, 屈留洋, 郑丹妮, 凌晓彤, 许晓韵, 柳登高. 1 812例唾液腺结石患者的人口学特征和临床特点[J]. 北京大学学报(医学版), 2026, 58(1): 153-159.
[4] 王月, 梁宇红. 繁茂型牙骨质-骨结构不良1例[J]. 北京大学学报(医学版), 2026, 58(1): 220-224.
[5] 郭博达, 陆敏, 王国良, 张洪宪, 刘磊, 侯小飞, 赵磊, 田晓军, 张树栋. 肾透明细胞癌与非透明细胞癌伴静脉癌栓患者的临床病理特征及预后比较[J]. 北京大学学报(医学版), 2025, 57(4): 644-649.
[6] 张展奕, 陆敏, 孙悦皓, 董靖晗, 侯小飞, 肖春雷, 王国良, 田晓军, 马潞林, 张洪宪, 张树栋. TFE3重排肾细胞癌合并静脉癌栓患者的临床病理特征及生存分析[J]. 北京大学学报(医学版), 2025, 57(4): 650-661.
[7] 王起, 柯涵炜, 丁泽华, 张维宇, 张晓鹏, 徐涛, 许克新. 耻骨后与经闭孔尿道中段悬吊术对术后最大尿流率及残余尿量的影响[J]. 北京大学学报(医学版), 2025, 57(4): 717-720.
[8] 刘帅, 刘茁, 管允鹤, 王国良, 田晓军, 张洪宪, 刘磊, 马潞林, 张树栋. 机器人辅助腹腔镜下腔静脉节段性切除术治疗肾肿瘤瘤栓侵犯血管壁[J]. 北京大学学报(医学版), 2025, 57(4): 796-802.
[9] 杨源源, 张珊珊, 俞光岩, 杨辉俊, 杨宏宇. 部分下颌下腺切除术治疗下颌下腺良性肿瘤的临床效果[J]. 北京大学学报(医学版), 2025, 57(2): 334-339.
[10] 仇师禹, 练洋, 康一帆, 张雷, 蔡义望, 单小峰, 蔡志刚. 基于下颌骨数据库和全连接神经网络的三维检索模型辅助下的下颌骨个性化重建[J]. 北京大学学报(医学版), 2025, 57(2): 360-368.
[11] 王菲, 张馨月, 刘木清, 王恩博, 段登辉. 顺牙长轴拔牙法在下颌近中与水平智齿拔除术中的应用及三维有限元分析[J]. 北京大学学报(医学版), 2025, 57(1): 106-112.
[12] 方媛媛, 徐帆, 雷杰, 张昊, 张文宇, 孙宇, 吴宏新, 傅开元, 毛伟玉. 基于颞下颌关节紊乱病诊断标准的临床自动诊断系统的建立及验证[J]. 北京大学学报(医学版), 2025, 57(1): 192-201.
[13] 石宇彤, 危伊萍, 胡文杰, 徐涛, 张浩筠. 罹患重度牙周炎下颌磨牙拔牙微翻瓣牙槽嵴保存效果评价[J]. 北京大学学报(医学版), 2025, 57(1): 33-41.
[14] 王昕莹, 程雪原, 张勇, 李菲, 段晋瑜, 乔静. 浓缩生长因子与自固化磷酸钙人工骨联合治疗牙周骨下袋缺损的疗效:临床和影像学评价[J]. 北京大学学报(医学版), 2025, 57(1): 42-50.
[15] 康一帆, 葛严军, 吕晓鸣, 谢尚, 单小峰, 蔡志刚. 即刻种植体支持式义齿修复的血管化髂骨瓣重建下颌骨缺损[J]. 北京大学学报(医学版), 2025, 57(1): 78-84.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!